• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Overview of the genetic basis toward early detection of breast cancer.乳腺癌早期检测的遗传基础概述。
Breast Cancer (Dove Med Press). 2019 Jan 21;11:71-80. doi: 10.2147/BCTT.S185870. eCollection 2019.
2
Overview of resistance to systemic therapy in patients with breast cancer.乳腺癌患者全身治疗耐药概述。
Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1.
3
[Breast cancer: an overview of factors affecting the onset and development of the disease].[乳腺癌:影响该疾病发病及发展因素的概述]
Cas Lek Cesk. 2002 Feb 15;141(3):80-4.
4
Health-related quality of life in early breast cancer.早期乳腺癌患者的健康相关生活质量
Dan Med Bull. 2010 Sep;57(9):B4184.
5
Molecular Action and Clinical Relevance of Aromatase Inhibitors.芳香化酶抑制剂的分子作用及临床相关性
Oncologist. 1998;3(2):129-130.
6
Breast cancer and ovarian cancer genetics.乳腺癌与卵巢癌遗传学
J Long Term Eff Med Implants. 2005;15(5):533-45. doi: 10.1615/jlongtermeffmedimplants.v15.i5.60.
7
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.美国临床肿瘤学会政策声明更新:癌症易感性基因检测
J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11.
8
Early diagnosis and detection of breast cancer.乳腺癌的早期诊断与检测
Technol Health Care. 2018;26(4):729-759. doi: 10.3233/THC-181277.
9
Liquid biopsy in breast cancer: A comprehensive review.乳腺癌中的液体活检:全面综述。
Clin Genet. 2019 Jun;95(6):643-660. doi: 10.1111/cge.13514. Epub 2019 Feb 27.
10
Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.BRCA 突变携带者的双侧预防性乳房切除术:外科医生需要了解的内容。
Ann Ital Chir. 2019;90:1-2.

引用本文的文献

1
Integrated computational and preclinical evaluation of novel synthetic pyrazole pyrazoline thiazole derivative for breast cancer therapeutics.新型合成吡唑并吡唑啉噻唑衍生物用于乳腺癌治疗的综合计算和临床前评估
Sci Rep. 2025 Aug 26;15(1):31412. doi: 10.1038/s41598-024-83046-7.
2
A smartphone-colorimetric dual-mode diagnosis method for breast cancer detection of BRCA-1 gene base on silver plated substrate and catalytic hairpin assembly amplification.一种基于镀银基底和催化发夹组装扩增的用于乳腺癌BRCA-1基因检测的智能手机比色双模式诊断方法。
J Nanobiotechnology. 2025 Apr 2;23(1):266. doi: 10.1186/s12951-025-03340-y.
3
Comprehensive breast cancer risk analysis with whole exome sequencing and the prevalence of and mutations and oncogenic HPV.采用全外显子组测序进行全面的乳腺癌风险分析以及BRCA1和BRCA2突变与致癌性人乳头瘤病毒(HPV)的流行情况
Biomed Rep. 2024 Aug 7;21(4):144. doi: 10.3892/br.2024.1832. eCollection 2024 Oct.
4
Breast Cancer High-Penetrance Genes BRCA1 and BRCA2 Mutations Using Next-Generation Sequencing Among Iraqi Kurdish Women.伊拉克库尔德女性中使用下一代测序技术检测乳腺癌高穿透性基因BRCA1和BRCA2突变
Cureus. 2024 Jun 11;16(6):e62160. doi: 10.7759/cureus.62160. eCollection 2024 Jun.
5
Circulating exosomal miRNAs as a promising diagnostic biomarker in cancer.循环外泌体 miRNA 作为癌症有前景的诊断生物标志物。
Physiol Res. 2023 Oct 27;72(S3):S193-S207. doi: 10.33549/physiolres.935153.
6
Investigate the application of postoperative ctDNA-based molecular residual disease detection in monitoring tumor recurrence in patients with non-small cell lung cancer--A retrospective study of ctDNA.探讨基于术后循环肿瘤DNA(ctDNA)的分子残留病检测在非小细胞肺癌患者肿瘤复发监测中的应用——一项关于ctDNA的回顾性研究
Front Oncol. 2023 Apr 6;13:1098128. doi: 10.3389/fonc.2023.1098128. eCollection 2023.
7
Mitochondrial genome in sporadic breast cancer: A case control study and a proteomic analysis in a Sinhalese cohort from Sri Lanka.散发性乳腺癌中的线粒体基因组:来自斯里兰卡僧伽罗人群的病例对照研究和蛋白质组学分析。
PLoS One. 2023 Feb 9;18(2):e0281620. doi: 10.1371/journal.pone.0281620. eCollection 2023.
8
Sociodemographic, Clinical, and Variation Outcomes for Breast Cancer and Breast Cancer-Related Mutations in a Ten-Year Cohort From Neiva, Huila, Colombia.哥伦比亚胡利亚省内瓦市十年队列中乳腺癌及乳腺癌相关突变的社会人口统计学、临床和变异结果
Cureus. 2022 Dec 6;14(12):e32257. doi: 10.7759/cureus.32257. eCollection 2022 Dec.
9
Peptide-Based Vaccines in Clinical Phases and New Potential Therapeutic Targets as a New Approach for Breast Cancer: A Review.基于肽的疫苗在乳腺癌治疗中的临床阶段及新潜在治疗靶点:综述
Vaccines (Basel). 2022 Aug 3;10(8):1249. doi: 10.3390/vaccines10081249.
10
Role of adipose tissue-derived cytokines in the progression of inflammatory breast cancer in patients with obesity.脂肪组织来源的细胞因子在肥胖患者炎症性乳腺癌进展中的作用。
Lipids Health Dis. 2022 Aug 4;21(1):67. doi: 10.1186/s12944-022-01678-y.

本文引用的文献

1
Risk Reduction Strategies in Breast Cancer Prevention.乳腺癌预防中的风险降低策略。
Eur J Breast Health. 2017 Jul 1;13(3):103-112. doi: 10.5152/ejbh.2017.3583. eCollection 2017 Jul.
2
Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies.游离DNA(cfDNA):新兴技术塑造的癌症临床意义及应用
Mol Cancer Res. 2016 Oct;14(10):898-908. doi: 10.1158/1541-7786.MCR-16-0044. Epub 2016 Jul 15.
3
PALB2: research reaching to clinical outcomes for women with breast cancer.PALB2:针对乳腺癌女性患者临床结局的研究
Hered Cancer Clin Pract. 2016 Apr 19;14:9. doi: 10.1186/s13053-016-0049-2. eCollection 2016.
4
Epidermal Growth Factor Receptor Expression in Triple Negative and Nontriple Negative Breast Carcinomas.三阴性和非三阴性乳腺癌中表皮生长因子受体的表达
J Lab Physicians. 2015 Jul-Dec;7(2):79-83. doi: 10.4103/0974-2727.163129.
5
Postmenopausal hormone therapy and the risk of breast cancer in Norway.挪威绝经后激素治疗与乳腺癌风险
Int J Cancer. 2016 Feb 1;138(3):584-93. doi: 10.1002/ijc.29810. Epub 2015 Sep 3.
6
Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.乳腺癌中微小RNA的失调及其在患者管理中作为预后和预测生物标志物的潜在作用。
Breast Cancer Res. 2015 Feb 18;17:21. doi: 10.1186/s13058-015-0526-y.
7
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
8
ATM gene mutations in sporadic breast cancer patients from Brazil.巴西散发性乳腺癌患者的ATM基因突变
Springerplus. 2015 Jan 15;4:23. doi: 10.1186/s40064-015-0787-z. eCollection 2015.
9
Genomic Instability and Cancer.基因组不稳定与癌症。
J Carcinog Mutagen. 2014;5. doi: 10.4172/2157-2518.1000165.
10
Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada.加拿大安大略省东部BRCA1和BRCA2基因阴性的乳腺癌和/或卵巢癌家族中PALB2基因的突变分析。
Hered Cancer Clin Pract. 2014 Aug 28;12(1):19. doi: 10.1186/1897-4287-12-19. eCollection 2014.

乳腺癌早期检测的遗传基础概述。

Overview of the genetic basis toward early detection of breast cancer.

作者信息

De Silva Sumadee, Tennekoon Kamani Hemamala, Karunanayake Eric Hamilton

机构信息

Institute of Biochemistry, Molecular Biology and Biotechnology, University of Colombo, Colombo, Sri Lanka,

出版信息

Breast Cancer (Dove Med Press). 2019 Jan 21;11:71-80. doi: 10.2147/BCTT.S185870. eCollection 2019.

DOI:10.2147/BCTT.S185870
PMID:30718964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6345186/
Abstract

Cancer is a socioeconomical burden in any nation. Out of that, breast cancer is identified as the most common malignancy worldwide among women irrespective of age. As women are an important segment in a community, the weakening of their strength toward the development of a nation is a critical problem in each nation. In this review, it was aimed to discuss the characteristics of cancer genome, cancer genetics, and cancer epigenetics in general and then focus on discussing both genetic and nongenetic factors responsible for the predisposition of breast cancer in humans. More emphasis was placed on genes responsible for the early onset of the disease and which can be used as genetic tools in the identification of the disease at an early stage. Then the context of genetic involvement toward the breast cancer occurrence before age of 40 years was highlighted accordingly. In addition to genetic testing, the review paid adequate attention to mention novel liquid biopsy techniques and other clinical, laboratory, and radiologic assessments. These techniques can be used in early detection and recurrence as well as the surveillance of the patients after primary therapies.

摘要

癌症在任何国家都是一种社会经济负担。其中,乳腺癌被认为是全球女性中最常见的恶性肿瘤,不分年龄。由于女性是社会的重要组成部分,她们对国家发展的力量削弱在每个国家都是一个关键问题。在这篇综述中,旨在总体讨论癌症基因组、癌症遗传学和癌症表观遗传学的特征,然后着重讨论导致人类乳腺癌易感性的遗传和非遗传因素。更多的重点放在了导致疾病早期发病且可作为早期识别该疾病的遗传工具的基因上。然后相应地强调了40岁之前遗传因素对乳腺癌发生的影响。除了基因检测,该综述还充分关注提及了新型液体活检技术以及其他临床、实验室和放射学评估。这些技术可用于早期检测、复发以及原发性治疗后患者的监测。